Historically, anaplastic thyroid cancer (ATC) has been one of the most aggressive and challenging forms of cancer to treat, with traditional methods often resulting in poor survival rates. Treatment has remained a significant struggle, causing dismay for both patients and healthcare providers.
The Institute of Cancer Research (ICR) in London is teaming up with Healx, a biotech firm known for its expertise in artificial intelligence (AI) and machine learning, to develop potential new therapies for diffuse intrinsic pontine glioma (DIPG), a rare and currently untreatable form of childhood
The digital health landscape in 2024 has been marked by unexpected developments, rapid advancements, and new challenges. Industry executives have reflected on the year's most surprising and impactful occurrences, providing insights into the evolving dynamics of healthcare technology. This article
The release of Thermo Scientific™ Amira™ Software Version 2024.2 marks a significant milestone in the field of image analysis, particularly for cellular ultrastructure analysis. This new version introduces a suite of advanced tools and features designed to enhance precision, efficiency, and overall
Recent research has delved into the cognitive limitations of large language models (LLMs), or "chatbots," when subjected to dementia screening tests traditionally used on humans. The study, published in the Christmas issue of The BMJ, reveals that almost all leading LLMs exhibit signs of mild
The recent announcement by Russia regarding the development of a groundbreaking mRNA cancer vaccine represents a significant milestone in the global fight against cancer. Scheduled for free distribution in early 2025, this innovative vaccine has captured worldwide attention due to its potential to